Effect of clopidogrel on bleeding after coronary artery bypass surgery
- 1 December 2001
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 29 (12), 2271-2275
- https://doi.org/10.1097/00003246-200112000-00006
Abstract
Platelet dysfunction is a common cause of bleeding after coronary artery bypass graft surgery. This study explores the effects of clopidogrel on bleeding complications after coronary artery bypass graft surgery. Prospective observational study of patients undergoing coronary artery bypass graft. Tertiary care center. A total of 247 patients undergoing coronary artery bypass graft surgery. None. Primary end point was need for reexploration secondary to bleeding. Secondary end points included need for transfusion of blood products and chest tube output. Eight (3.3%) of 247 patients required reexploration secondary to bleeding. Clopidogrel recipients had higher incidence of reexploration for bleeding (9.8 vs. 1.6, p = .01) with an odds ratio of 6.9 (95% confidence interval, 1.6–30). Clopidogrel also increased the percentage of patients receiving packed red blood cell transfusion (72.6 vs. 51.6%, p = .007), the number of packed red blood cell units (3 vs. 1.6, p =0.0004), and the number of cryoprecipitate units (2.4 vs. 1.2, p = .04) transfused after coronary artery bypass graft surgery. Among clopidogrel recipients, a trend for increased transfusion of platelet units (4.3 vs. 1.7, p = .05) and fresh frozen plasma units (1.1 vs. 0.6, p = .08) also was found. Preoperative use of clopidogrel in combination with aspirin is associated with increased need for surgical reexploration as well as risk of packed red blood cell and cryoprecipitate transfusions after coronary artery bypass graft surgery.Keywords
This publication has 13 references indexed in Scilit:
- Trends in rates of reexploration for hemorrhage after coronary artery bypass surgeryThe Annals of Thoracic Surgery, 1999
- Ticlopidine and ClopidogrelCirculation, 1999
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1998
- Reexploration for Hemorrhage Following Coronary Artery Bypass GraftingIncidence and Risk FactorsArchives of Surgery, 1998
- Aprotinin for Primary Coronary Artery Bypass Grafting: A Multicenter Trial of Three Dose RegimensThe Annals of Thoracic Surgery, 1996
- Aspirin Does Not Increase Allogeneic Blood Transfusion in Reoperative Coronary Artery SurgeryAnesthesia & Analgesia, 1996
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Bleeding complications associated with cardiopulmonary bypassBlood, 1990
- Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass graftingJournal of the American College of Cardiology, 1990
- Bleeding after Cardiopulmonary BypassNew England Journal of Medicine, 1986